AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |
Back to Blog
Chimera syndrome12/24/2023 However, a few scenarios give pause to this conclusion and disease specific assessment of chimerism requirement is necessary. Chimerismįull donor chimerism is often unnecessary in NMD provided lineage specific engraftment is adequate to cure or suppress disease manifestations. We will focus on the chimerism aspect of success following HCT for NMD. Successful HCT does not guarantee reversal of non-hematopoietic abnormalities and outcomes are variable depending on disorder, graft source, conditioning regimen, toxicity, and other factors. Ensuring adequate and stable donor engraftment to effectively suppress disease manifestations or afford a cure in timely manner has a major role in determining outcomes and success when HCT is contemplated for NMD. The safety and efficacy of the procedure factors into the decision on how to, when to, and what to monitor post-transplant. Though HCT is curative, the risk-benefit ratio between disease manifestations and HCT outcomes should be carefully considered. As the number of disorders benefiting from transplant increase, expansion of donor sources that will best serve to mitigate disease manifestations is advantageous. As identification of genetic abnormalities become more sophisticated, indications for curative transplant are expected to rise. HCT results in immunohematologic replacement and thus corrects pathophysiology in NMD such as immune deficiencies and dysregulation, metabolic disorders, hemoglobinopathies, and bone marrow failure disorders. The overall aim of HCT is to correct the pathologic basis of hematologic, immunologic, or enzymatic dysfunction that is the etiology of the underlying disease. These can vary from chronic supportive care needs and poor quality of life to rapid progression and early mortality. Hematopoietic stem cell transplantation (HCT) is a curative option in a variety of inherited and acquired non-malignant disorders (NMD) that present at varying age groups, progress at variable rates, and have a wide range of clinical manifestations. We draw attention to knowledge gaps and areas of necessity for further research and research support. In this perspective, we will discuss current knowledge of the role of chimerism and goals, approach to HCT, and emerging methods of boosting engraftment and graft function, and monitoring recommendations. The addition of donor factors such as stem cell source and Human-Leukocyte-Antigen match extend the complexity such that ‘one size does not fit all'. An enhanced ability to reject grafts due to recipient immune competence, alloimmunization, and autoimmunity add to the complexity of this balance making NMD a highly diverse group of unrelated disorders. However, the levels of donor chimerism conducive to disease control vary between NMD, need to focus on the hematopoietic lineage necessary to correct individual disorders, and need to be assessed for stability over time, i.e., a whole lifespan. This allows for exploration of reduced intensity conditioning regimens that can limit organ toxicity, late effects, and increase tolerability especially in young recipients or those with a large burden of disease related morbidity. Unlike hematologic malignancies where complete replacement with donor derived hematopoiesis is desirable for a cure, NMD manifestations can often be controlled in the presence of mixed chimerism. Stability or reversal of disease symptoms depends on adequacy and long-term stability of donor cell engraftment in the compartment of interest. Hematopoietic stem cell transplantation (HCT) is a curative intervention in non-malignant disorders (NMD) that benefit from donor-derived hematopoiesis, immunity, and establishment of vital cells or enzyme systems. Department of Pediatrics, Washington University School of Medicine, St.If my actions are smothered, then my words will have to speak loud enough for all of us. Because if I'm going to be silenced, then I won't go without a fight. I'm afraid I'm falling deeper and will have no way out. These are my symptoms, and it's becoming too much. You can't distinguish faces, and the ones you manage to are featureless and fanged. You can't see straight, all noises are in slow motion. Your blood drains from your thumbs, your eyes and ears. There's a flash, and then everything's still. Have you ever felt not knowing how to feel? Pain, anger, grief, fear? I think we all have, but do you know what happens when all these things merge together? I can feel the stress of my situation caving in around me, and it's overwhelming. All that I know and have known, had I not experienced it myself, I would have excused my so called knowledge as hallucinations battered with nightmares and illness.
0 Comments
Read More
Leave a Reply. |